Andros Pharmaceuticals Co.,Ltd (TPEX:6917)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
40.80
+6.95 (20.53%)
Apr 20, 2026, 1:24 PM CST
Market Cap1.85B +117.1%
Revenuen/a
Net Incomen/a
EPSn/a
Shares Out45.37M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,000
Average Volume813,443
Open34.30
Previous Close33.85
Day's Range34.20 - 41.20
52-Week Range15.70 - 41.15
Beta-0.35
RSI90.05
Earnings Daten/a

About TPEX:6917

Andros Pharmaceuticals Co.,Ltd, a biopharmaceutical company, engages in developing novel drug delivery platform technologies. The company develops APC101, a fast-drying, film-forming, and meter-dosed spray, which is in Phase IIa clinical trial to treat pain associated with post-herpetic neuralgia; APC201, a novel dosage form of topical anesthetic that is in Phase I/II clinical trial for treatment of Osteoarthritis; and siRNA, an anti-sense oligonucleotide and DNA candidate. Its preclinical phase products are APC310 and APC501 for anesthesia to ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6917
Full Company Profile